Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA5 | P31644 | 5/20 | 0.34 |
| ▸ | CFTR | P13569 | 3/20 | 0.33 |
| ▸ | RAF1 | P04049 | 2/20 | 0.31 |
| ▸ | BRAF | P15056 | 2/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23905870 | 1.00 | GABRA5 (0.34) | GABRA5CFTRRAF1BRAFNR3C1 | |
| SCHEMBL23905868 | 1.00 | GABRA5 (0.34) | GABRA5CFTRRAF1BRAFNR3C1 | |
| SCHEMBL24988033 | 0.93 | GABRA5 (0.35) | GABRA5CFTR | |
| SCHEMBL23905865 | 0.93 | GABRA5 (0.34) | GABRA5CFTRRAF1BRAF | |
| SCHEMBL23905315 | 0.93 | GABRA5 (0.34) | GABRA5CFTRRAF1BRAF | |
| SCHEMBL23905256 | 0.92 | CFTR (0.34) | GABRA5CFTR | |
| SCHEMBL23905595 | 0.92 | CFTR (0.34) | GABRA5CFTR | |
| SCHEMBL23905580 | 0.92 | CFTR (0.32) | GABRA5CFTR | |
| SCHEMBL23905249 | 0.92 | CFTR (0.33) | GABRA5CFTRRAF1BRAFNR3C1 | |
| SCHEMBL23905541 | 0.92 | CFTR (0.33) | GABRA5CFTRRAF1BRAFNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021198981-A1 | ANTIVIRAL COMPOUNDS AND USES THEREOF | Janssen Biopharma, Inc. (US) | 2021-10-07 | — | — | WO | disclosed |